Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001508799-10-000003
Filing Date
2010-12-27
Accepted
2010-12-27 11:39:54
Documents
2
Period of Report
2010-12-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 8648
2 POWER OF ATTORNEY loberg.txt EX-24 3510
  Complete submission text file 0001508799-10-000003.txt   14153
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 31121 BROOKS STREET LAGUNA BEACH CA 92651
Business Address
Loberg Philip Walden Jr (Reporting) CIK: 0001508799 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 101273735